This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Ozempic
  • /
  • Efficacy and Safety of Semaglutide Once-weekly Ver...
Clinical trial

Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes (SUSTAIN� 5)

Read time: 3 mins
Last updated:1st Dec 2014
Identifier: NCT02305381
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest